Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia

Journal of Human Hypertension

Volumn 15, Issue 3, 2001, Pages 185-190

  Bofinger, A ^a   Hawley, C ^a   Fisher, P ^a   Daunt, N ^a   Stowasser, M ^a   Gordon, R D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Aetiology; Fibromuscular dysplasia; Gene polymorphisms; Renal artery; Renin angiotensin system; Renovascular hypertension

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FIBROMUSCULAR DYSPLASIA; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; KIDNEY ARTERY; KIDNEY ARTERY STENOSIS; MALE; POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; RESTENOSIS; TISSUE LEVEL; VASCULAR SMOOTH MUSCLE;

EID: 0035127631     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001144     Document Type: Article

References (56)

1. Arterial fibromuscular dysplasia
2. Roentgen diagnosis of fibromuscular hyperplasia of the renal arteries
3. Hypertension caused by fibromuscular hyperplasia of the renal arteries
4. Idiopathic fibrous and fibromuscular stenoses of the renal arteries associated with hypertension
5. The genetics of fibromuscular dysplasia
6. Possible familial origin of multifocal renal artery fibromuscular dysplasia
7. Fibromuscular dysplasia of arteries: A spastic phenomenon?
8. Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers
9. Etiologic factors in renovascular fibro-muscular dysplasia. A case-control study
10. Cigarette smoking and renovascular hypertension
11. Smoking and renal artery stenosis
12. The potential role of angiotensin II in the vasculature
13. Bioactive angiotensin peptides
14. Enzymatic reactions of the renin-angiotensin system
15. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells
16. Angiotensin II induces smooth muscle proliferation in the normal and injured rat arterial wall
17. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury
18. Inhibition of converting enzyme and neointima formation after vascular injury in rats and guinea pigs
19. Role of angiotensin II in injury-induced neointima formation in rats
20. Effect of ramipril, an inhibitor of angiotensin converting enzyme, on the response of rat thoracic aorta to injury with a balloon catheter
21. Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries
22. Pathologic classification of renal arterial disease in renovascular hypertension
23. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system
24. Vascular remodeling and mineralocorticoids
25. Aldosterone and spironolactone in heart failure
26. Adrenal steroids and cardiac fibrosis
27. Genetic risk for renal artery stenosis: Association with deletion polymorphism in angiotensin 1-converting enzyme gene
28. Molecular basis of human hypertension: Role of angiotensinogen
29. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
30. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging
31. Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients
32. Plasma angiotensin-converting enzyme activity and carotid wall thickening
33. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno study
34. Deletion polymorphism in angiotensin converting enzyme gene associated with carotid wall thickening in a healthy male population
35. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study
36. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting
37. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: A major risk factor and a marker of risk for coronary stent restenosis
38. Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study
39. Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplasty
40. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty
41. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty
42. Genetic study of renal artery fibromuscular dysplasia
43. Serial renal function and angiographic observations in idiopathic fibrous and fibromuscular stenoses of the renal arteries
44. Hypertension and fibromuscular dysplasia of the renal arteries
45. The natural history of atherosclerotic and fibrous renal artery disease
46. Fibromuscular dysplasia of the renal arteries. Arteriographic features, classification, and observations on natural history of the disease
47. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease
48. Ddel polymorphism in the AGTR1 gene
49. Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy
50. Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans
51. Vascular angiotensin-converting enzyme expression regulates local angiotensin II
52. Estrogen regulation of angiotensin-converting enzyme mRNA
53. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS
54. Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys
55. Serum angiotensin-converting enzyme activity in pregnancy-induced hypertension
56. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in post-menopausal women